Call For Abstracts, Registration, And Hotel Reservations Now Open For Worldsymposiumtm 2026 In San Diego, Ca

(MENAFN- EIN Presswire)

More than 2,000 experts from 50+ countries will gather in San Diego for WORLDSymposiumTM 2026, the premier lysosomal disease meeting.

WORLDSymposiumTM 2026, Feb 2–6 in San Diego, unites 2,000 participants from 50+ countries to advance lysosomal disease research.

WORLDSymposium is the place for emerging and established investigators to present data that shapes the future of lysosomal disease diagnosis, treatment, and care.” - Professor Roberto Giugliani, MD, PhDMINNEAPOLIS, MN, UNITED STATES, August 28, 2025 /EINPresswire / -- WORLDSymposium recently announced that abstract submissions, award nominations, attendee registration, and hotel reservations are now open for the 22nd annual WORLDSymposium, taking place February 2-6, 2026, at the Manchester Grand Hyatt in San Diego, California, United States.

As the largest international meeting focused on lysosomal diseases, WORLDSymposium advances the global conversation around diagnosis, treatment, and therapeutic innovation. Now in its third decade, the meeting attracts 2,000 participants annually from more than 50 countries – including experts in basic science, translational research, clinical applications, regulatory strategy, and industry development.

Since 2002, WORLDSymposium has evolved from a focused gathering of lysosomal disease researchers to a comprehensive, cross-disciplinary platform that bridges laboratory discovery and human therapy. Each year's program reflects the meeting's core objective: to examine, discuss, and surpass the scientific, clinical, and logistical challenges involved in translating lysosomal disease research from bench to bedside.

Abstract Submission Open Until October 1
The abstract submission portal is now open for submissions. Abstracts submitted on or before the deadline of October 1, 2025, at 17:00 CDT will be reviewed by the WORLDSymposium Scientific Committee for potential platform or poster presentation. Notifications will be issued by November 4, 2025.

A separate Late-Breaking Abstract category will be available November 1 - December 1, 2025, for investigators with new and impactful data that was not available by the primary deadline.

“WORLDSymposium is the one scientific meeting everyone involved in lysosomal disease research should attend every year. It is the place for emerging and established investigators to present data that shapes the future of lysosomal disease diagnosis, treatment, and care. There is no other meeting like WORLDSymposium.”

–Professor Roberto Giugliani, MD, PhD, Professor of Genetics, Federal University of Rio Grande do Sul, and Executive Director of Casa dos Raros, in Porto Alegre, Brazil.

Award Nominations
Nominations for the 2026 WORLDSymposium Awards , including the annual Roscoe O. Brady, Patient Advocate Leader, New Treatment and Catalyst Awards, which honor innovation, advocacy, new therapies, and emerging leadership, are open through September 3, 2025.

Registration and Lodging
General registration is open at worldsymposia . Attendees are encouraged to register early and secure accommodations within the official room block at the Manchester Grand Hyatt, the designated host venue for WORLDSymposium 2026. Rooms are available on a first-come, first-served basis and are expected to fill quickly.

About WORLDSymposium
WORLDSymposium (We're Organizing Research on Lysosomal Diseases) is an annual global medical education conference focused on lysosomal diseases. Now in its 22nd year, the meeting brings together 2,000 researchers, clinicians, patient advocates, and industry professionals from over 50 countries to exchange knowledge and advance the field. The 2026 Annual Scientific Meeting will be held February 2-6, 2026, at the Manchester Grand Hyatt in San Diego, California. Along with Chester B. Whitley, PhD, MD, as the founder and Course Director for WORLDSymposium, the annual scientific program is jointly managed by Etherio and Saterdalen & Associates, LLC.

Sarah Jansen
WORLDSymposium c/o Etherio Group
+1 630-571-4529
email us here
Visit us on social media:
LinkedIn
Facebook
X

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

MENAFN28082025003118003196ID1109989379